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An Obligatory Role of NF-kB in Mediating Bone Marrow
Derived Endothelial Progenitor Cell Recruitment and
Proliferation Following Endotoxemic Multiple Organ
Injury in Mice
Sun-Zhong Mao1,2, Xiaobing Ye1, Gang Liu1, Dongmei Song1, Shu Fang Liu1,2*
1 Centers for Heart and Lung Research and Pulmonary and Critical Care Medicine, the Feinstein Institute for Medical Research, Manhasset, New York, United States of
America, 2 Institute of Hypoxia Medicine, Wenzhou Medical University, Wenzhou, Zhejiang, China

Abstract
Background: Recruitment of bone marrow derived endothelial progenitor cells (BMDEPCs) alleviates multiple organ injury
(MOI) and improves outcomes. However, mechanisms mediating BMDEPC recruitment following septic MOI remain largely
unknown. This study characterized the kinetics of BMDEPC recruitment and proliferation and defined the role of NF-kB in
regulating BMDEPC recruitment and proliferation.
Methods and Main Findings: Chimeric mice with an intact or disrupted NF-kB p50 gene and BMDEPC-restricted expression
of green fluorescent protein were created and injected with LPS (2 mg/kg, i.p.). BMDEPC recruitment and proliferation in
multiple organs were quantified. BMDEPC recruitment and proliferation are highly organ-dependent. Lungs had the highest
number of BMDEPC recruitment, whereas heart, liver and kidney had only a small fraction of the number of BMDEPCs in
lungs. Number of proliferating BMDEPCs was several-fold higher in lungs than in other 3 organs. Kinetically, BMDEPC
recruitment into different organs showed different time course profiles. NF-kB plays obligatory roles in mediating BMDEPC
recruitment and proliferation. Universal deletion of NF-kB p50 gene inhibited LPS-induced BMDEPC recruitment and
proliferation by 95% and 69% in heart. However, the contribution of NF-kB to these regulations varies significantly between
organs. In liver, universal p50 gene deletion reduced LPS-induced BMDEPC recruitment and proliferation only by 49% and
35%. NF-kB activities in different tissue compartments play distinct roles. Selective p50 gene deletion either in stromal/
parenchymal cells or in BM/blood cells inhibited BMDEPC recruitment by a similar extent. However, selective p50 gene
deletion in BM/blood cells inhibited, but in stromal/parenchymal cells augmented BMDEPC proliferation.
Conclusions: BMDEPC recruitment and proliferation display different kinetics in different organs following endotoxemic
MOI. NF-kB plays obligatory and organ-dependent roles in regulating BMDEPC recruitment and proliferation. NF-kB
activities in different tissue compartments play distinct roles in regulating BMDEPC proliferation.
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correlated with better prognosis and survival rate [7–9]. Animal
experiments demonstrated that exogenously administered EPCs or
other SPCs blunted systemic and organ inflammation, alleviated
organ damage [10–13], reduced endothelial permeability [14] and
improved survival [11,14,15]. The strong anti-injury and organ
protective effects of EPCs/SPCs suggest that enhancing EPCs/
SPCs recruitment could be a good strategy for treating MOI. In
this regard, elucidation of mechanisms and pathways regulating
EPC/SPC recruitment and proliferation in injured organ may
provide important information guiding the development of such a
therapy. However, studies characterizing the kinetics of EPC
recruitment and proliferation following septic MOI are rare.

Introduction
Multiple organ injury (MOI) is associated with remarkably
increased mobilization and recruitment of endothelial progenitor
cells (EPCs) and other stem/progenitor cells (SPCs) from bone
marrow (BM). Although whether and how BM-derived EPCs/
SPCs contribute to organ repair are subjects of intense debate [1–
6], it is generally agreed that an increased recruitment of BMderived EPCs/SPCs, either from mobilization of endogenous
EPCs/SPCs or by administration of exogenous EPCs/SPCs, has
beneficial effects [5–24]. Clinical studies showed that patients with
organ injury had increased numbers of circulating EPCs, which
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GFP) mouse strain by crossbreeding between p50-KO and Tie2GFP mice. The NG mice are deficient in NF-kB p50 gene in all
cell types and express GFP on endothelial lineage cells. We then
created WT-GFP-BM, p50-GFP-BM, WT-NG-BM or p50-NGBM chimeric mouse strain by transplanting lethally irradiated wild
type (WT), p50-KO, WT or p50-KO mice with BMs from the
Tie-GFP or NG mice. The p50-GFP-BM, WT-NG-BM or p50NG-BM chimeras are deficient in NF-kB p50 gene in stromal/
parenchymal cells, in BM/blood cells or in all cell types. All 4
chimeric mouse strains overexpress GFP in BMDEPCs in a cellrestricted manner. A description of the mouse strains used for this
study was given in Table S1.

Mechanisms and pathways regulating EPC recruitment following
septic MOI remain largely to be elucidated, although there is
limited information available in mechanical arterial injury and
atherosclerotic renal artery stenosis models [25,26].
Recent studies showed that EPCs/SPCs conferred protection
against organ injury and improved outcomes by paracrine
mechanisms: by secreting immunomodulating mediators [15–18]
and/or angiogenic factors [19,20], and by transferring mitochondria, protein or microRNA to resident cells in injured organ via
the release of microvesicles/exosomes [21,22], or via direct cellcell interactions [23,24]. Thus, communications between BMderived EPCs (BMDEPCs) and stromal/parenchymal cells could
be critical for BMDEPC-mediated anti-injury actions. However,
little is known about the mechanisms and pathways regulating the
intercellular communications. In this regard, deciphering the role
of individual compartment-specific signaling in the regulation of
EPC recruitment and function may shed some light. No such a
study has been reported.
NF-kB is a multi-faceted transcription factor that plays
important roles in many cellular, physiological and pathological
processes [27–29]. NF-kB is a key mediator of immune and
inflammatory responses [29], but also plays a role in inflammation
resolution [30]. The antiapoptotic and proliferative actions of NFkB in parenchymal cells may contribute to organ repair [31],
whereas this NF-kB function in macrophages and other inflammatory cells promotes inflammation [27,29]. NF-kB regulates
tissue homeostasis [32] and energy balance [33]. Although the
contributions of NF-kB to organ inflammation and injury have
been extensively studied [29,33–37], the potential role of NF-kB in
organ repair is less clear. Since MOI is associated with remarkably
increased BMDEPC recruitment, NF-kB may play a role in
regulating BMDEPC recruitment and proliferation following
MOI. This potential function of NF-kB has not been studied.
This study characterized the kinetics of BMDEPC recruitment
and proliferation, defined the role of NF-kB in regulating
BMDEPC recruitment and proliferation, and deciphered the role
of compartment-specific NF-kB activity in this regulation following endotoxemic MOI. We created several new chimeric mouse
strains with universal or cell type-restricted deletion of NF-kB p50
gene and BMDEPC-restricted overexpression of green fluorescent
protein (GFP). Using these mouse models, we demonstrated that
BMDEPC recruitment and proliferation displayed different
kinetics in different organs following endotoxemic MOI. NF-kB
played obligatory and organ-dependent roles in mediating
BMDEPC recruitment and proliferation. NF-kB activity in
different tissue compartment played distinct role in regulating
BMDEPC proliferation. Our data provides important new insights
into the mechanisms regulating BMDEPC recruitment and
proliferation following endotoxemic MOI.

Bone marrow transplant
Recipient mice (6–8 weeks) received a lethal dose of whole body
X-ray irradiation (900 Rads) and transplanted with donor BM
cells. Donor mice were euthanized. The femurs and tibias were
removed aseptically and marrow cavities flushed with Ca++,
Mg++-free Hanks’ Balanced Salt Solution. Single cell suspension
was prepared, washed twice, counted, and resuspended in sterile
RPMI medium at 36107cells/ml prior to transplantation. Each
irradiated recipient was injected with 16107 BM cells through tail
vein.
Two months after BM transplantation, the chimeras were used
for experiments or tissue collection. At the completion of
experiment, mice were euthanized and BM collected. Reconstitution of recipient BM with donor BM cells was confirmed and
degree of donor BM chimerism analyzed by fluorescence activated
cell sorting.

Fluorescence activated cell sorting (FACS)
To evaluate BM chimerism, BM mononuclear cells were
isolated from donors, recipients and chimeras using Ficoll density
gradient centrifugation, and stained with PE/Cy7-anti-CD31 (BD
Biosciences, San Jose, CA) plus Alexa Fluor 488-anti-GFP (Life
Technologies, Grand Island, NY) antibodies. Fluorescence minus
one controls were stained in parallel in all analyses. Cells were
analyzed using FACS to determine percentage of GFP+ EPCs in
BM mononuclear cell population. Degree of donor chimerism was
determined by comparing percentage of GFP+ EPCs between
each chimera and its respective donor.

Assessment of LPS-induced MOI
Control or LPS group of WT mice were injected with saline
(1 ml/kg, i.p.) or Escherichia coli LPS (0111:B4, 2 mg/kg, i.p.).
Organ inflammation and injury were assessed 24 hours after LPS
injection by histological examination, by measuring tissue level of
myeloperoxidase (MPO) activity (as an indicator of neutrophil
infiltration), as we have previously described [34], and by
measuring tissue level of IL-6 using IL-6 ELISA kits (eBioscience,
San Diego, CA).

Materials and Methods
Animal models

Quantification of recruited and proliferating BMDEPCs

All animal experiments were approved by Institutional Animal
Care and Use Committee of the Feinstein Institute for Medical
Research (Number, 2012-033), and were carried out in strict
accordance with the recommendations in the Guide for the Care
and Use of Laboratory Animals of the National Institutes of
Health. Mice deficient in NF-kB p50 gene (p50-KO) and
transgenic mice overexpressing GFP on endothelial lineage cells
(Tie2-GFP) were purchased from Jackson Laboratory (Bar
Harbor, ME). The p50-KO mice were on C57BL/6 genetic
background and were backcrossed to FVB genetic background for
at least 6 generations. We initially created a new NG (p50-KOPLOS ONE | www.plosone.org

Two months after BM transplantation, the chimeric mice were
injected with saline (controls) or LPS (2 mg/kg, i.p.). The in situ
cell proliferation kit (Roche Diagnostics, Branchburg, NJ) was used
for in situ detection of proliferating BMDEPCs. To label
proliferating cells in vivo, mice were injected with bromodeoxyuridine (BrdU, 100 mg/kg, i.v.) 4 hours prior to tissue collection.
For studying time course of BMDEPC recruitment and
proliferation, cryosections of heart, lungs, liver and kidney were
prepared from control mice and mice 12, 24, 48, 96 or 144 hours
after LPS injection, fixed with paraformaldehyde, permeabilized,
2
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which would include all BMDEPCs and a small portion (,0.5%)
of BM-derived hematopoietic progenitor cells.
Two months after BM transplantation, mice were injected with
saline or LPS, and then with bromodeoxyuridine (BrdU) 4 hours
prior to tissue collection to label proliferating cells in vivo.
BMDEPCs recruited into or proliferating in heart, lungs, liver and
kidney were identified by GFP staining or BrdU plus GFP double
staining, and counted.
MOI was associated with a remarkably increased BMDEPCs
recruitment. However, both the quantities and kinetics of
BMDEPC recruitment varied significantly with organs (Fig. 1).
The lung had the highest number of BMDEPC recruitment, but
liver, heart and kidney had only 1/3, 1/4 and 1/9 of the number
of BMDEPCs in lungs at the peak of BMDEPC recruitment
(Fig. 1). Number of recruited BMDEPCs was in the order of
lung . liver . heart . kidney. Kinetically, BMDEPCs entered
into liver earlier. BMDEPC recruitment peaked at 12 hours in
liver, but peaked at 24 hours post-LPS in heart, lungs and kidney
(Fig. 1). On other hand, number of BMDEPCs decreased to
control level by 96 hours in heart, but remained significantly
higher than control in lungs, liver and kidney even at 144 hours
post-LPS (Fig. 1).
Likewise, an organ-dependent variation in BMDEPC proliferation was observed. Number of proliferating BMDEPCs was 2-, 3and 4-fold higher in lungs than in heart, liver and kidney at peak of
BMDEPC proliferation. Number of proliferating BMDEPCs
peaked at 24 hours in all 4 organs, and remained at the peak
level at 48 hours post-LPS in heart, lungs and kidney, but not in
liver. In liver, number of proliferating BMDEPCs has decreased to
42% of its peak level at 48 hours (Fig. 2). At 96 hours, number of
proliferating BMDEPCs decreased to control level in heart, lungs
and liver, but not in kidney (Fig. 2).

stained with anti-GFP (genetic marker for BMDEPCs) antibody or
stained with anti-GFP plus anti-BrdU (marker for proliferating
cells) antibodies (Abcam, Cambridge, MA), followed by Alexa
Fluor 594 conjugated or/and Alexa Fluor 488 conjugated
secondary antibody (Invitrogen, Carlsbad, CA). Nuclei were
counterstained with 49, 6-diamidino-2-phenylindole (DAPI).
Numbers of GFP+ cells (BMDEPCs) or GFP+/BrdU+ cells
(proliferating BMDEPCs) were counted and expressed as a
percentage of total cells as revealed by DAPI nuclear staining.
To examine the effects of NF-kB p50 gene deletion on
BMDEPC recruitment and proliferation, the numbers of GFP+
BMDEPCs or GFP+/BrdU+ proliferating BMDEPCs in the 4
organs were compared between WT-GFP-BM and p50-NG-BM,
p50-GFP-BM or WT-NG-BM chimeric mice.

Electrophoretic mobility shift assay (EMSA)
To confirm that p50 gene deletion in p50-NG-BM chimera
blocks LPS-induced NF-kB activation, we compared LPS-induced
NF-kB binding activity between WT-GFP-BM and p50-NG-BM
mice. Nuclear proteins were extracted from heart, lungs, liver and
kidney. NF-kB DNA binding activity was measured by EMSA
using 32P-labeled NF-kB consensus oligonucleotide as we have
previously described [37]. The specificity of NF-kB DNA binding
was confirmed in competition reactions in which 50-fold molar
excess unlabelled NF-kB oligonucleotide was added to the binding
reaction 10 minutes prior to the addition of labeled probe.

Statistical analysis
Data were expressed as mean 6 SEM and analyzed using
ANOVA or Kruskal-Wallis rank test followed by Holm-Sidak
method or Student-Newman-Keuls Method for post hoc analysis.
The null hypothesis was rejected at 5% level.

Results

P50 gene deletion inhibits LPS-induced NF-kB activity in
chimeric mice

Characterization of BMDEPC recruitment and
proliferation following endotoxemic MOI

We inhibited NF-kB activity using p50-KO mice. We have
previously demonstrated that LPS-induced NF-kB complex is
composed predominantly of p50/p65 heterodimer with minimal
p50/50 homodimers [37]. The lack of p50 protein in p50-KO
mice diminishes or greatly reduces nuclear translocation of p50/
p65 heterodimer, leading to an inhibition of NF-kB activation.
To examine the effects of systemic or compartment-selective
blockade of NF-kB activity on BMDEPC recruitment and
proliferation, we generated 4 chimeric mouse strains: WT-GFPBM, p50-NG-BM, p50-GFP-BM and WT-NG-BM that carry an
intact p50 gene or a disrupted p50 gene in all cell types, in
stromal/parenchymal cells or in BM/blood cells, and overexpress
GFP on BMDEPCs. A description of those mouse strains was
given in Table S1. Two months after BM transplantation, we
confirmed high degree of BM chimerism of the 4 chimeras by
showing that BM cells of the chimeras were 92% to 95% of donor
BM origin (Fig. S2).
To confirm that p50 gene deletion blocks LPS-induced NF-kB
activation in the chimeras, WT-GFP-BM and p50-NG-BM mice
were injected with LPS and NF-kB DNA binding activity
measured. EMSA showed that LPS induced a markedly increased
NF-kB binding activity in heart, lungs, liver and kidney in WTGFP-BM, which was diminished or greatly reduced in all 4 organs
of p50-NG-BM mice (Fig. 3). This result confirms that p50 gene
deletion blocks LPS-induced NF-kB activation in the chimeras.

To better understand the mechanisms regulating BMDEPC
recruitment and proliferation, we first characterized the profiles of
BMDEPC recruitment and proliferation in multiple organs
following endotoxemic MOI. The p50-NG-BM mice are extremely sensitive to LPS. We found that LPS at 5 mg/kg (i.p.)
produced a mortality rate of ,95% by 24 hours in p50-NG-BM
mice. This study used low dose LPS (2 mg/kg, i.p.), which has
been previously shown to induce organ injury in lung [38], kidney
[39] and liver [40]. Here, we demonstrated that this low dose of
LPS caused inflammation, neutrophil infiltration and histological
evidence of tissue injury in lungs, liver and kidney (Fig. S1),
confirming that this dose of LPS causes MOI.
We generated WT-GFP-BM chimeras and confirmed high level
of BM chimerism by demonstrating that 95% of BM cells in the
chimeras were donor BM origin (Fig. S2A). Tie2 is reported to be
expressed on a subset of hematopoietic cells [41]. However, a
phenotypic characterization of lung cells from the Tie2-GFP mice
demonstrated that 89.5% of all GFP+ cells are CD452/CD31+
endothelial lineage cells, and only 0.4% of them are CD45+/
CD31+ hematopoietic cells [3]. Since CD31+ BM-derived
hematopoietic progenitor cells have strong angiogenic and
vasculogenic capacities, and high ability to give rise to new
endothelial cells [42], the CD31+ BM-derived hematopoietic
progenitor cells and BMDEPCs are likely to play similar roles in
alleviating organ injury or/and in promoting organ repair. It is,
therefore, not necessary to differentiate one from another in this
study. We referred all BM-derived GFP+ cells as BMDEPCs,
PLOS ONE | www.plosone.org

Effect of P50 gene deletion on BMDEPC recruitment
We next examined the effect of p50 gene deletion on LPSinduced BMDEPC recruitment using WT-GFP-BM and p503
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Figure 1. Time course profiles of BMDEPC recruitment into multiple organs. WT-GFP-BM mice were injected with saline (Con) or LPS (2 mg/
kg, i.p.), and organs harvested at 12, 24, 48, 96 and 144 hours after LPS injection. Cryosections were prepared and stained with green fluorescence
protein (GFP, genetic marker of BMDEPC) antibody and nuclei counterstained with DAPI (4, 6-diamidino-2-phenylindole). Number of GFP+ bone
marrow derived endothelial progenitor cells (BMDEPCs) on each slide from heart (A), lungs (B), liver (C) and kidney (D) was counted and expressed as
a percentage of total cells as revealed by DAPI nuclear staining. Mean 6 SEM of 5 mice per group. *, p,0.05, compared with control group. There
was an organ-dependent variation in numbers and kinetics of BMDEPC recruitment.
doi:10.1371/journal.pone.0111087.g001

NG-BM mice (Table S1). Cryosections of heart, lungs, liver and
kidney were prepared at 24 and 48 hours after saline or LPS
injection, and stained with anti-GFP antibody. GFP+ BMDEPCs
were counted and expressed as a percentage of total cells as
revealed by DAPI nuclear staining. Number of BMDEPCs
increased markedly in all 4 organs of WT-GFP-BM mice at 24
and 48 hours post-LPS (Fig. 4). LPS-induced BMDEPC recruitment was reduced by 95%, 81% and 72% at 48 hours post-LPS
in heart, lungs and kidney of p50-NG-BM mice, whose p50 gene
was deleted in all cells (Fig. 4). This result indicates an obligatory
role for NF-kB in mediating LPS-induced BMDEPC recruitment
into multiple organs.
Using WT-NG-BM and p50-GFP-BM mice (Table S1), we
deciphered the roles of BM/blood cell and stromal/parenchymal
cell intrinsic NF-kB activities in regulating BMDEPC recruitment.
Selective deletion of p50 gene in BM/blood cells (WT-NG-BM) or
in stromal/parenchymal cells (p50-GFP-BM) reduced the number
of recruited BMDEPCs by a similar extent (Fig. 5 gray and black
bars), suggesting that NF-kB activities in the two compartments
contribute equally to the regulation of LPS-induced BMDEPC
recruitment.
The levels of inhibition of LPS-induced BMDEPC recruitment
achieved by p50 gene deletion, either universal or compartmentselective, varied significantly between organs. Among the 4 organs,
p50 gene deletion caused the highest inhibition in heart and the
lowest inhibition in liver. The % inhibition of BMDEPC
recruitment by universal p50 gene deletion was heart . lungs .
kidney . liver (Figs. 4 and 5).
PLOS ONE | www.plosone.org

Effect of P50 gene deletion on BMDEPC proliferation
Proliferation is an important mechanism by which BMDEPCs
mediate endothelial and organ repair. We examined the role of
NF-kB in regulating BMDEPC proliferation. The chimeric mice
were injected with saline or LPS, and then with bromodeoxyuridine (BrdU) to label proliferating cells in vivo 4 hours prior to
tissue collection. Cryosections from heart, lungs, liver and kidney
were prepared and stained with anti-GFP plus anti-BrdU
antibodies. GFP+/BrdU+ proliferating BMDEPCs were counted
and expressed as a percentage of total cells as revealed by DAPI
nuclear staining.
LPS caused a marked increase in number of proliferating
BMDEPCs in all 4 organs of WT-GFP mice. Systemic NF-kB
blockade by universal p50 gene deletion (p50-NG mice) significantly reduced number of proliferating BMDEPCs in all 4 organs
(Fig. 6). However, the levels of inhibition varied significantly
among organs. At 24 and 48 hours post-LPS, universal p50 gene
deletion inhibited LPS-induced BMDEPC proliferation by 58%
and 70% in kidney, but only by 27% and 34% in lungs (Fig. 6). At
48 hours post-LPS, universal p50 gene deletion did not significantly inhibit LPS-induced BMDEPC proliferation in liver
(Fig. 6). The % inhibition of BMDEPC proliferation by universal
p50 gene deletion was kidney . heart . liver . lung.
BM/blood cell and stromal/parenchymal cell intrinsic NF-kB
activities play opposite roles in regulating BMDEPC proliferation.
Selective deletion of p50 gene in BM/blood cells (WT-NG mice)
significantly inhibited, but in stromal/parenchymal cells (p50-GFP

4
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Figure 2. Characterization of BMDEPC proliferation in multiple organs. WT-GFP-BM mice were injected with saline (Con) or LPS and BrdU
(100 mg/kg, i.v., to label proliferating cells). Organs were harvested at 12, 24, 48 or 96 hours after LPS and 4 hours after BrdU injection. Cryosections
were prepared and stained with GFP plus BrdU antibodies to identify proliferating BMDEPCs, and nuclei counterstained with DAPI. Number of GFP+/
BrdU+ proliferating BMDEPCs on each slide from heart (A), lung (B), liver (C) and kidney (D) was counted and expressed as a percentage of total cells
as revealed by DAPI nuclear staining. Mean 6 SEM of 5 mice per group. *, p,0.05, compared with control group. There was an organ-dependent
variation in numbers and kinetics of BMDEPC proliferation.
doi:10.1371/journal.pone.0111087.g002

Figure 3. Electrophoretic mobility shift assay (EMSA) autoradiographs show that p50 gene deletion blocks LPS-induced NF-kB
activation. WT-GFP-BM and p50-NG-BM mice were injected with saline (Con) or LPS, and organs harvested 6 hours post-LPS. Nuclear protein was
extracted and NF-kB DNA binding activity in heart (A), lungs (B), liver (C) and kidney (D) was measured by EMSA using 32P-labeled NF-kB
oligonucleotide probe. Representative of 3 independent experiments.
doi:10.1371/journal.pone.0111087.g003

PLOS ONE | www.plosone.org
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Figure 4. Systemic blockade of NF-kB activity inhibits BMDEPC recruitment in multiple organs. WT-GFP-BM and p50-NG-BM mice were
injected with saline (Con) or LPS, and organs harvested at 24 and 48 hours post-LPS. Cryosections were prepared and stained with GFP antibody and
nuclei counterstained with DAPI. Number of GFP+ BMDEPCs on each slide from heart (A), lung (B), liver (C) and kidney (D) was counted, expressed as
a percentage of total cells as revealed by DAPI nuclear staining, and compared between WT-GFP-BM and p50-NG-BM mice. Mean 6 SEM of 5 mice
per group. *, p,0.05, compared with controls. #, p,0.05, compared with WT-GFP-BM mice at 24 or 48 hours.
doi:10.1371/journal.pone.0111087.g004

several findings that have not previously been reported, and
demonstrated several interesting conclusions that may improve
our understanding of the mechanisms of BMDEPC recruitment
and proliferation following endotoxemic MOI.
First, both the quantities and kinetics of BMDEPC recruitment
and proliferation are highly organ-dependent. Different organs of
same animal had different numbers of BMDEPC recruitment.
The difference was more than 9-fold between organs with the
highest and lowest BMDEPC recruitment. Likewise, numbers of
proliferating BMDEPCs differed markedly between organs of the
same animal. The difference was more than 8-fold between organs
with the highest and lowest BMDEPC proliferation. Kinetically,
BMDEPC recruitment and proliferation in different organs
followed different time courses. BMDEPC recruitment reached
its peak at 12 hours post-LPS in liver, but at 24 hours in other 3
organs. On other hand, number of recruited BMDEPCs returned
to control level in heart by 96 hours, but retained significantly
higher than control in lungs, liver or kidney even 144 hours postLPS. BMDEPC proliferation in different organs showed different
time course profiles. At 48 hours post-LPS, number of proliferating BMDEPCs has decreased to less than half of its peak value in
liver, while number of proliferating BMDEPCs remained at peak
level in lungs, heart and kidney.
Second, NF-kB activity plays obligatory and organ-dependent
roles in regulating BMDEPC recruitment and proliferation.
Systemic blockade of NF-kB activity by universal p50 gene
deletion markedly reduced numbers of recruited and proliferating
BMDEPCs in all organs studied, and the level of inhibition was
impressively high. At 48 hours post-LPS, universal p50 gene
deletion inhibited LPS-induced BMDEPC recruitment and
proliferation by 95% and 69% in heart, and by 72% and 70%
in kidney, suggesting that NF-kB plays obligatory roles in

mice) significantly augmented LPS-induced BMDEPC proliferation in all 4 organs (Fig. 7). There appeared to be an organdependent variation in the inhibition or augmentation of
BMDEPC proliferation caused by selective deletion of p50 gene
in BM/blood cells or in stromal/parenchymal cells (Figs. 7). At 24
and 48 hours post-LPS, selective p50 gene deletion in BM/blood
cells inhibited LPS-induced BMDEPC proliferation by 47% and
46% in kidney, but only by 22% and 27% in lungs (Figs. 7B and
7D, gray bars). At these time points, selective p50 gene deletion in
stromal/parenchymal cells augmented LPS-induced BMDEPC
proliferation by 21% and 65% in kidney, but by 63% and 67% in
lungs (Figs. 7B and 7D, black bars).

Discussion
While whether BMDEPCs contribute to endothelial and organ
repair remains a subject of intense debate, an increased
recruitment of BM-derived EPCs/SPCs has been consistently
demonstrated to have beneficial effects [5–24]. Enhancing
BMDEPC recruitment could be useful therapeutic strategy for
the treatment of MOI. Towards this end, we need to better
understand the mechanisms and pathways regulating BMDEPC
recruitment and proliferation following MOI. Elucidation of
mechanisms and pathways mediating BMDEPC recruitment and
proliferation in injured organs may also reveal microenvironmental factors that influence BMDEPC’s function in the injured
organs, which may provide important information guiding the
development of new approaches to improve BMDEPC-based cell
therapies. To our knowledge, this is the first study that
characterized the kinetics of BMDEPC recruitment and proliferation, and defined the role of NF-kB in regulating BMDEPC
recruitment and proliferation following septic MOI. We reported
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Figure 5. Selective blockade of stromal/parenchymal cell or BM/blood cell intrinsic NF-kB activity similarly inhibits BMDEPC
recruitment. WT-GFP-BM, p50-GFP-BM and WT-NG-BM mice were injected with saline (Con) or LPS, and organs were harvested at 24 and 48 hours
post-LPS. Cryosections were prepared and stained with GFP antibody and nuclei counterstained with DAPI. Number of GFP+ BMDEPCs on each slide
from heart (A), lung (B), liver (C) and kidney (D) was counted, expressed as a percentage of total cells as revealed by DAPI nuclear staining, and
compared between WT-GFP-BM and p50-GFP-BM, or WT-NG-BM mice. Mean 6 SEM of 5 mice per group. *, p,0.05, compared with controls. #, p,
0.05, compared with WT-GFP-BM mice at 24 or 48 hours. Blockade of intrinsic NF-kB activity in stromal/parenchymal cells (black bars) or in BM/blood
cells (gray bars) similarly inhibits BMDEPC recruitment.
doi:10.1371/journal.pone.0111087.g005

Figure 6. Systemic blockade of NF-kB activity inhibits BMDEPC proliferation in multiple organs. WT-GFP-BM and p50-NG-BM mice were
injected with saline (Con) or LPS and BrdU (to label proliferating cells). Organs were harvested at 24 and 48 hours after LPS and 4 hours after BrdU
injection. Cryosections were prepared and stained with GFP plus BrdU antibodies to identify proliferating BMDEPCs, and nuclei counterstained with
DAPI. Number of GFP+/BrdU+ proliferating BMDEPCs on each slide from heart (A), lung (B), liver (C) and kidney (D) was counted, expressed as a
percentage of total cells as revealed by DAPI nuclear staining, and compared between WT-GFP-BM and p50-NG-BM mice. Mean 6 SEM of 5 mice per
group. *, p,0.05, compared with controls. #, p,0.05, compared with WT-GFP-BM mice at 24 or 48 hours.
doi:10.1371/journal.pone.0111087.g006
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Figure 7. Selective blockade of BM/blood cell or stromal/parenchymal cell intrinsic NF-kB activity has opposite effects on BMDEPC
proliferation. WT-GFP-BM, WT-NG-BM and p50-GFP-BM mice were injected with saline (Con) or LPS and BrdU (to label proliferating cells). Organs
were harvested at 24 and 48 hours after LPS and 4 hours after BrdU injection. Cryosections were prepared and stained with GFP plus BrdU antibodies
to identify proliferating BMDEPCs, and nuclei counterstained with DAPI. Number of GFP+/BrdU+ proliferating BMDEPCs on each slide from heart (A),
lung (B), liver (C) and kidney (D) was counted, expressed as a percentage of total cells as revealed by DAPI nuclear staining, and compared between
WT-GFP-BM and WT-NG-BM or p50-GFP-BM mice. Mean 6 SEM of 5 mice per group. *, p,0.05, compared with controls. #, p,0.05, compared with
WT-GFP-BM mice at 24 or 48 hours. Blockade of intrinsic NF-kB activity in BM/blood cells (gray bars) inhibits, but in stromal/parenchymal cells (black
bars) augments BMDEPC proliferation.
doi:10.1371/journal.pone.0111087.g007

induced BMDEPC proliferation. NF-kB activities in the two
compartments play antagonistic roles in regulating BMDEPC
proliferation.
A question raised is that if NF-kB activities in stromal/
parenchymal and BM/blood cells played opposite roles in
regulating BMDEPC proliferation, why blockade of NF-kB
activities in both compartments by universal p50 gene deletion
inhibited BMDEPC proliferation? One possible explanation is that
the weak augmenting effect on BMDEPC proliferation was
masked by the strong inhibitory effect on BMDEPC recruitment.
Universal p50 gene deletion blocked stromal/parenchymal and
BM cell/blood cell NF-kB activities simultaneously. The stimulating and inhibiting effects on BMDEPC proliferation caused by
blocking stromal/parenchymal and BM/blood cell intrinsic NFkB activities were balanced. At the same time, blockade of NF-kB
activities in both compartments greatly reduced BMDEPC
recruitment. For example, numbers of recruited BMDEPCs were
reduced by 92% and 95% in the heart at 24 and 48 hours postLPS. As a consequence, the number of proliferating BMDEPCs
was significantly reduced by universal p50 gene deletion.
We observed that BMDEPCs were differentially recruited into
lungs, heart, liver and kidney. Mechanisms underlying the
different organ distribution of mobilized BMDEPCs are unclear,
but suggested that the ‘‘sieve’’ action of pulmonary capillary beds
may contribute to the high number of BMDEPC retention in
lungs. Trapping of substantial numbers of BMDEPCs in lung
capillary beds could reduce the number of BMDEPCs available
for distribution to downstream organs. However, this interpretation cannot explain the differences between other organs. Other

mediating BMDEPC recruitment and proliferation. However, NFkB appears to play complex and organ-dependent roles. The
extent of inhibition of BMDEPC recruitment and proliferation by
p50 gene deletion varied significantly with organs. At 24 hours
post-LPS, universal p50 gene deletion inhibited LPS-induced
BMDEPC recruitment by 92% in heart, but only by 49% in liver,
and inhibited LPS-induced BMDEPC proliferation by 58% in
kidney, but only by 27% in lungs.
NF-kB plays a complex role. Inhibition of BMDEPC proliferation was proportional to the inhibition of BMDEPC recruitment
in one organ, but was not proportional in another organ. At
48 hours post-LPS, universal p50 gene deletion inhibited LPSinduced BMDEPC proliferation and recruitment by 70% and
72% in kidney, but inhibited BMDEPC proliferation by 34% and
recruitment by 81% in lung, and inhibited proliferation by 35%
and recruitment by 66% in liver. This result suggests that NF-kB
plays complex roles in regulating BMDEPC proliferation and
recruitment.
Third, NF-kB activities in different tissue compartments play
distinct roles in regulating BMDEPC recruitment and proliferation. Both stromal/parenchymal and BM/blood cell intrinsic NFkB activities mediate BMDEPC recruitment. NF-kB activities in
the two compartments are synergistic in mediating BMDEPC
recruitment. Blockade of NF-kB activities in both compartments
by universal p50 gene deletion led to a significantly greater
inhibition of BMDEPC recruitment than blockade of NF-kB
activity in stromal/parenchymal cells or in BM/blood cells alone.
By contrast, BM/blood cell intrinsic NF-kB activity mediates, but
stromal/parenchymal cell intrinsic NF-kB activity inhibits LPSPLOS ONE | www.plosone.org
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factors must be considered. Differences in microenvironmental
factors and extent of injuries between organs may be important
factors that are worth considering. It was reported in an unilateral
kidney injury mouse model that EPCs were predominantly
recruited into the injured kidney, but not the contralateral control
kidney (2), indicating that different extent of injuries between
organs can affect BMDEPC recruitment.
The organ-dependent variation in kinetics and NF-kB-mediated
regulation of BMDEPC recruitment and proliferation suggests
that different types of organ injuries may stimulate BMDEPC
recruitment and proliferation via distinct mechanisms. Elucidation
of the mechanisms underlying the differential BMDEPC recruitment and proliferation in different organs, and the organdependent variation in NF-kB-mediated regulation of BMDEPC
recruitment and proliferation will greatly improve our understanding of the mechanisms of BMDEPC recruitment and
proliferation following septic MOI.
Depending on models, context, stimuli and partner protein with
which p50 interacts, NF-kB p50 has both pro- and antiinflammatory effects [29,36,37,43,46], so does p50 gene deletion.
P50 forms p50/p50/Bcl-3 (B-cell lymphoma 3-encoded protein) or
p50/p50/HDAC-1 (histone deacetylase-1) repressor complex,
which suppresses transcriptional expression of inflammatory genes
[43,44]. Under these circumstances, p50 gene deletion would
augment inflammation and exacerbate tissue injury. On other
hand, p50 form p50/p65 heterodimer, which mediates the
transcriptional expression of a large number of inflammatory
genes [29]. Under these conditions, p50 gene deletion would
inhibit inflammation and attenuate tissue injury [29,36,37,45,46].
We suggest that p50 gene deletion here inhibits BMDEPC
recruitment and proliferation by blocking the activation of the
canonical NF-kB pathway, which is characterized by I-kBa
degradation and nuclear translocation of p50/p65 heterodimer
[27–29]. We have previously demonstrated that I-kBa degradation was a prerequisite for LPS-induced NF-kB activation [29,37]
and that I-kBa overexpression blocked LPS-induced NF-kB
activation [34]. Our supershift assay revealed that LPS-induced
NF-kB complex is composed predominantly of p50/p65 heterodimer, and contains minimal p50/p50 homodimer [37]. We
demonstrated here that p50 gene deletion diminished or greatly
reduced LPS-induced NF-kB band in all 4 organs of the chimeric
mice. It is likely that the lack of p50 protein in p50-KO mice
diminishes nuclear translocation of p50/p65 heterodimer, leading
to an inhibition of NF-kB activation, which inhibits BMDEPC
recruitment and proliferation. Our data adds a new role to the
long list of functions that NF-kB plays.
In summary, we have created 4 chimeric mouse strains. Using
these mouse models, we demonstrated that BMDEPC recruitment
and proliferation displayed different characteristics and kinetics in
different organs following endotoxemic MOI. NF-kB plays
obligatory and organ-dependent roles in regulating BMDEPC
recruitment and proliferation. NF-kB activities in different tissue
compartments play distinct roles in the regulations. Both stromal/
parenchymal and BM/blood cell intrinsic NF-kB activities
mediate BMDEPC recruitment. By contrast, BM/blood cell
intrinsic NF-kB activity mediates, but stromal/parenchymal cell
intrinsic NF-kB activity inhibits BMDEPC proliferation. Our data

provides new insights into the mechanisms regulating BMDEPC
recruitment and proliferation following endotoxemc MOI.

Supporting Information
Figure S1 Low-dose LPS causes organ inflammation
and injury in multiple organs. Control and LPS groups of
wild type mice were injected with saline or LPS (2 mg/kg, i.p.). At
24 hours after LPS injection, organ histology was evaluated, and
tissue levels of IL-6 and myeloperoxidase (MPO) activity
measured. A. Representative photographs of H&E staining of
lung, kidney and liver sections show that LPS causes organ injury.
Sections from the 3 organs of LPS-challenged mice exhibited
increased inflammatory cell infiltration, alveolar, kidney sinusoidal
and liver central vein congestion, and scattered areas of
hemorrhage. Lung section showed an increased alveolar wall
thickness and alveolar collapse. Kidney section showed signs of
tubular swelling and cell injury. Liver section showed signs of
hepatic cell injury. Scale bar, 50 mm. B. Bar graphs show that LPS
causes marked increase in tissue levels of IL-6 in lung, kidney and
liver. Mean 6 S.M.E. of 5 mice per group. *: p,0.05, compared
to control group. C. Bar graphs show that LPS markedly increases
tissue levels of MPO activity in lung, kidney and liver. Mean 6
S.M.E. of 5 mice per group. *: p,0.05, compared to control
group.
(PDF)
Figure S2 FACS analysis of BM chimerism. Two months
after BM transplant, BM mononuclear cells (BMMNCs) were
isolated from donors, recipients and chimeras, stained with CD31
plus GFP antibodies, and analyzed. The degree of BM chimerism
was evaluated based on percentage of donor-derived CD31+/
GFP+ endothelial progenitor cells (EPCs) in BMMNC population
of the chimera. A. Representative FACS pictures show percentage
of CD31+/GFP+ EPCs (upper right quadrant) in BMMNCs from
Tie2-GFP (donor), WT-GFP-BM (chimera) and WT (recipient)
mice, demonstrating high degree of BM chimerism. B. Representative FACS pictures show percentage of CD31+/GFP+ EPCs
(upper right quadrant) in BMMNCs of Tie2-GFP (donor), p50GFP-BM (chimera) and NF-kB p50 gene knock out (p50-KO,
recipient) mice, demonstrating high degree of BM chimerism. C.
Representative FACS pictures show percentage of CD31+/GFP+
EPCs (upper right quadrant) in BMMNCs of NG (p50-KO-GFP,
donor), WT-NG-BM (chimera), and WT(recipient) mice, demonstrating high degree of donor BM chimerism. D. Representative
FACS pictures show percentage of CD31+/GFP+ EPCs (upper
right quadrant) in BMMNCs of NG (p50-KO-GFP, donor), p50NG-BM (chimera), and p50-KO (recipient) mice, demonstrating
high degree of donor BM chimerism.
(PDF)
Table S1 Mouse strains used.

(PDF)
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